-
ASCO GI | Advancing Targeted Therapy for Gastric Cancer: Insights from Dr. Anna Dorothea Wagner
Oncology Frontier: Could you please introduce the current status of virtual targeted treatment for gastric cancer? Dr. Anna Dorothea Wagner: It’s my pleasure to respond to this question. Currently, adding…
-
Dr. Zefei Jiang ‘s Overview of Breast Cancer Research Progress in 2023
In 2023, significant progress has been made in the field of breast cancer research. Dr. Zefei Jiang from The Fifth Medical Center of Chinese PLA General Hospital shared his insights and research findings at several important conferences. This article delves into Professor Jiang’s speeches, exploring the key advancements in breast cancer treatment in 2023.
-
Unlocking New Potential: Insights from the LAPIS Phase 3 Trial on Pamrevlumab in Locally Advanced Pancreatic Cancer
Editor’s note: The LAPIS Phase 3 trial was a large-scale, global, double-blind, placebo-controlled study designed to assess the efficacy of pamrevlumab in combination with chemotherapy for patients with locally advanced…
-
The 8th Yunling Breast Cancer Summit Forum | Dr. Qianjun Chen: Focusing on Controversies in HER2-Positive Breast Cancer, Multidisciplinary Collaboration Holds Great Promise
On July 14, to mark the 40th anniversary of Yunnan Cancer Hospital, the “8th Yunling Breast Cancer Summit Forum,” hosted by the Yunnan Anti-Cancer Association and the Chinese Medical Education Association, was held in Kunming. The event gathered cutting-edge advances in breast cancer from domestic and international experts. Dr. Qianjun Chen from Guangdong Provincial Hospital…
-
NIAGARA Study: A Potential New Standard for Muscle-Invasive Bladder Cancer?
The Phase 3 NIAGARA trial, presented at ASCO GU 2025, provides compelling evidence supporting perioperative durvalumab (D) plus neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC). The study highlights significant…
-
Blood Science Update: Gut Microbiota in Benign and Malignant Hematopoiesis
This article, published in the esteemed journal Blood Science, highlights the intricate role of gut microbiota in hematopoiesis, encompassing its influence on both benign and malignant conditions. As a peer-reviewed platform at the forefront of clinical and experimental hematology, Blood Science is recognized for its impact on advancing our understanding of molecular biology, physiology, and…
-
Blood Science Update: Epigenetic Modifications in Hematopoietic Ecosystem: A Key Tuner from Homeostasis to Acute Myeloid Leukemia
Blood Science, an authoritative journal in the fields of hematology and oncology, has been at the forefront of advancing knowledge in blood-related disorders. Dedicated to publishing pioneering research, the journal provides a platform for understanding the complexities of blood ecosystems, from cellular mechanisms to clinical implications. By fostering collaboration and disseminating groundbreaking studies, Blood Science…
-
Blood Science Update: New Insights into the Endothelial Origin of the Hematopoietic System
This article, published in the journal Blood Science, elucidates groundbreaking advancements in understanding the endothelial origins of the hematopoietic system. As a leading platform in clinical and experimental hematology, Blood Science continues to publish high-impact research that transforms molecular biology and physiology. Authored by Professor Yu Lan from the Key Laboratory for Regenerative Medicine of…
Connecting Medical Expertise through Media